Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
7.25
-0.05 (-0.75%)
At close: Aug 15, 2025, 2:34 PM

Quoin Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.01M -8.69M -9.38M -21.46M
Depreciation & Amortization
100K 103.71K 104.04K 104.04K
Stock-Based Compensation
1.26M 1.09M 764.01K n/a
Other Working Capital
-278.09K 41.42K 123.45K -18.68K
Other Non-Cash Items
-209.05K -471.31K 127.06K 14.31M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-2.14K 95.2K -94.35K 1.33M
Operating Cash Flow
-7.86M -7.86M -8.48M -5.72M
Capital Expenditures
n/a 3.77 -250K -625K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-17.25B -18.04M -9.9M n/a
Sales Maturities Of Investments
26.93B 20.23M 14.88B n/a
Other Investing Acitivies
-9.68B 5.64K -14.88B n/a
Investing Cash Flow
-1.89M 2.19M -10.15M -625K
Debt Repayment
-600K -600K -311.67K 3.48M
Common Stock Repurchased
n/a n/a -14.82M n/a
Dividend Paid
n/a n/a -65.27M n/a
Other Financial Acitivies
-54.9K -17.51K 64.77M -80.83K
Financial Cash Flow
10.97M 5.22M 14.01M 13.5M
Net Cash Flow
1.22M -459.43K -4.62M 7.16M
Free Cash Flow
-7.86M -7.86M -8.73M -6.35M